Cancer Drug Development Problems and Opportunities


The pharmaceutical industry must direct additional focus on the development of agents to prevent or minimize symptoms of cancer and its treatment, and maximize the quality of life of cancer patients. This paper covers the current status of cancer chemotherapy, opportunties for intervention, supportive care measures, and challenges to the pharmuceutical industry in oncologic drug development.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 189

This is the net price. Taxes to be calculated in checkout.

Author information

Correspondence to Maurie Markman MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Markman, M. Cancer Drug Development Problems and Opportunities. Ther Innov Regul Sci 32, 1–5 (1998).

Download citation

Key Words

  • Cancer
  • Oncologic drug development
  • Pharmaceutical industry